MARKET

NBIX

NBIX

Neurocrine Biosciences Inc
NASDAQ
120.76
+3.89
+3.33%
Opening 10:56 05/14 EDT
OPEN
117.58
PREV CLOSE
116.87
HIGH
121.85
LOW
116.00
VOLUME
436.79K
TURNOVER
--
52 WEEK HIGH
157.98
52 WEEK LOW
84.23
MARKET CAP
11.95B
P/E (TTM)
40.93
1D
5D
1M
3M
1Y
5Y
1D
Neurocrine Biosciences To Present BofA Securities 2025 Health Care Conference; Webcast At 2:20 PM ET
NASDAQ · 21h ago
Xenon Q1 Loss Narrower Than Expected, Pipeline Development in Focus
NASDAQ · 22h ago
Should Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) Be on Your Investing Radar?
NASDAQ · 1d ago
Weekly Report: what happened at NBIX last week (0505-0509)?
Weekly Report · 2d ago
Earnings Tell The Story For Neurocrine Biosciences, Inc. (NASDAQ:NBIX) As Its Stock Soars 27%
Simply Wall St · 3d ago
Neurocrine’s Growth Potential: Buy Rating Backed by Ingrezza and Crenessity Success
TipRanks · 5d ago
Neurocrine Biosciences First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St · 5d ago
Neurocrine’s Crenessity shows efficacy in Phase 3 CAH,study
TipRanks · 6d ago
More
About NBIX
More
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. The Company is engaged in discovering and developing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. Its diverse portfolio includes the United States Food and Drug Administration-approved treatments for tardive dyskinesia, chorea associated with Huntington’s disease, endometriosis and uterine fibroids, as well as a robust pipeline, including multiple compounds in mid-to late-phase clinical development across its core therapeutic areas. Its commercial products include INGREZZA, ALKINDI, EFMODY, Orilissa, and Oriahnn. INGREZZA is marketed as DYSVAL (valbenazine) in Japan and REMLEAS (valbenazine) in other select Asian markets, where Mitsubishi Tanabe Pharma Corporation retains commercialization rights. ALKINDI is marketed as ALKINDI SPRINKLE (hydrocortisone) in the United States, where Eton Pharmaceuticals, Inc. retains commercialization rights.
Recently
Symbol
Price
%Change

Webull offers Neurocrine Biosciences Inc stock information, including NASDAQ: NBIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NBIX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NBIX stock methods without spending real money on the virtual paper trading platform.